These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

346 related articles for article (PubMed ID: 11403732)

  • 1. Cotinine binding to nicotinic acetylcholine receptors in bovine chromaffin cell and rat brain membranes.
    Vainio PJ; Tuominen RK
    Nicotine Tob Res; 2001 May; 3(2):177-82. PubMed ID: 11403732
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antagonism of nicotinic receptors of rat chromaffin cells by N,N, N-trimethyl-1-(4-trans-stilbenoxy)-2-propylammonium iodide: a patch clamp and ligand binding study.
    Di Angelantonio S; Nistri A; Moretti M; Clementi F; Gotti C
    Br J Pharmacol; 2000 Apr; 129(8):1771-9. PubMed ID: 10780985
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Time and brain region specific up-regulation of low affinity neuronal nicotinic receptors during chronic nicotine administration in mice.
    Nuutinen S; Ahtee L; Tuominen RK
    Eur J Pharmacol; 2005 May; 515(1-3):83-9. PubMed ID: 15894304
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interaction of the catecholamine release-inhibitory peptide catestatin (human chromogranin A(352-372)) with the chromaffin cell surface and Torpedo electroplax: implications for nicotinic cholinergic antagonism.
    Taupenot L; Mahata SK; Mahata M; Parmer RJ; O'Connor DT
    Regul Pept; 2000 Nov; 95(1-3):9-17. PubMed ID: 11062327
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identified spinal motoneurons of young rats possess nicotinic acetylcholine receptors of the heteromeric family.
    Ogier R; Liu X; Tribollet E; Bertrand D; Raggenbass M
    Eur J Neurosci; 2004 Nov; 20(10):2591-7. PubMed ID: 15548202
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chronic nicotine administration does not increase nicotinic receptors labeled by [125I]epibatidine in adrenal gland, superior cervical ganglia, pineal or retina.
    Dávila-García MI; Musachio JL; Kellar KJ
    J Neurochem; 2003 Jun; 85(5):1237-46. PubMed ID: 12753083
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Surface and intracellular nicotinic receptors expressed in intact adrenal chromaffin cells: direct measurements using [3H]epibatidine.
    Free RB; McKay DB
    Brain Res; 2003 Jun; 974(1-2):60-9. PubMed ID: 12742624
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [3H]Epibatidine binding to bovine adrenal medulla: evidence for alpha3beta4* nicotinic receptors.
    Free RB; Bryant DL; McKay SB; Kaser DJ; McKay DB
    Neurosci Lett; 2002 Jan; 318(2):98-102. PubMed ID: 11796195
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential agonist inhibition identifies multiple epibatidine binding sites in mouse brain.
    Marks MJ; Smith KW; Collins AC
    J Pharmacol Exp Ther; 1998 Apr; 285(1):377-86. PubMed ID: 9536034
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of (+/-)(-)[3H]epibatidine binding to nicotinic cholinergic receptors in rat and human brain.
    Houghtling RA; Dávila-García MI; Kellar KJ
    Mol Pharmacol; 1995 Aug; 48(2):280-7. PubMed ID: 7651361
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterisation of the binding of [3H]methyllycaconitine: a new radioligand for labelling alpha 7-type neuronal nicotinic acetylcholine receptors.
    Davies AR; Hardick DJ; Blagbrough IS; Potter BV; Wolstenholme AJ; Wonnacott S
    Neuropharmacology; 1999 May; 38(5):679-90. PubMed ID: 10340305
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ligand specificity of nicotinic acetylcholine receptors in rat spinal cord: studies with nicotine and cytisine.
    Khan IM; Yaksh TL; Taylor P
    J Pharmacol Exp Ther; 1994 Jul; 270(1):159-66. PubMed ID: 8035312
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Agonist-induced up-regulation of alpha4beta2 nicotinic acetylcholine receptors in M10 cells: pharmacological and spatial definition.
    Whiteaker P; Sharples CG; Wonnacott S
    Mol Pharmacol; 1998 May; 53(5):950-62. PubMed ID: 9584223
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epibatidine binding sites and activity in the spinal cord.
    Khan IM; Yaksh TL; Taylor P
    Brain Res; 1997 Apr; 753(2):269-82. PubMed ID: 9125412
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ABT-594 [(R)-5-(2-azetidinylmethoxy)-2-chloropyridine]: a novel, orally effective analgesic acting via neuronal nicotinic acetylcholine receptors: I. In vitro characterization.
    Donnelly-Roberts DL; Puttfarcken PS; Kuntzweiler TA; Briggs CA; Anderson DJ; Campbell JE; Piattoni-Kaplan M; McKenna DG; Wasicak JT; Holladay MW; Williams M; Arneric SP
    J Pharmacol Exp Ther; 1998 May; 285(2):777-86. PubMed ID: 9580626
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacological similarities between native brain and heterologously expressed alpha4beta2 nicotinic receptors.
    Shafaee N; Houng M; Truong A; Viseshakul N; Figl A; Sandhu S; Forsayeth JR; Dwoskin LP; Crooks PA; Cohen BN
    Br J Pharmacol; 1999 Nov; 128(6):1291-9. PubMed ID: 10578144
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacological evaluation of a Br-76 analog of epibatidine: a potent ligand for studying brain nicotinic acetylcholine receptors.
    Kassiou M; Bottlaender M; Loc'h C; Dolle F; Musachio JL; Coulon C; Ottaviani M; Dannals RF; Maziere B
    Synapse; 2002 Aug; 45(2):95-104. PubMed ID: 12112402
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diversity of nicotinic acetylcholine receptors in rat hippocampal neurons. III. Agonist actions of the novel alkaloid epibatidine and analysis of type II current.
    Alkondon M; Albuquerque EX
    J Pharmacol Exp Ther; 1995 Aug; 274(2):771-82. PubMed ID: 7543571
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of nicotinic responses by cotinine in bovine adrenal chromaffin cells.
    Vainio PJ; Viluksela M; Tuominen RK
    Pharmacol Toxicol; 1998 Nov; 83(5):188-93. PubMed ID: 9834966
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [3H]A-585539 [(1S,4S)-2,2-dimethyl-5-(6-phenylpyridazin-3-yl)-5-aza-2-azoniabicyclo[2.2.1]heptane], a novel high-affinity alpha7 neuronal nicotinic receptor agonist: radioligand binding characterization to rat and human brain.
    Anderson DJ; Bunnelle W; Surber B; Du J; Surowy C; Tribollet E; Marguerat A; Bertrand D; Gopalakrishnan M
    J Pharmacol Exp Ther; 2008 Jan; 324(1):179-87. PubMed ID: 17959745
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.